Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ganglioside antigens are a class of complex glycolipids, specifically glycosphingolipids containing one or more sialic acid residues, that are predominantly found in the plasma membranes of cells within the nervous system. They play critical roles in cellular growth and differentiation, modulation of signal transduction, immune responses, and serve as cell surface antigens or receptors for various molecules including bacterial toxins. Certain gangliosides are overexpressed on tumor cells, making them attractive targets for cancer immunotherapy.
Monoclonal antibody binding to ganglioside antigens on tumor cells, leading to cell death; Immunomodulation to reduce antiganglioside antibody production
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ganglioside Antigens.